Mood & Mental Health

·

News

First Trial of IV Psilocin for Binge Eating Disorder Launches

First Trial of IV Psilocin for Binge Eating Disorder Launches

Psilocybin mushrooms

What they found

Swinburne University is launching the first clinical trial of IV psilocin for binge eating disorder.

Swinburne University is launching the first clinical trial of IV psilocin for binge eating disorder.

How solid is it?

n/a

n/a

Not a study

Not a study

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocin

psilocin

Published in

www.swinburne.edu.au

www.swinburne.edu.au

Covered in Shroom Scan

Section

PSILOCYBIN & LEGISLATION

PSILOCYBIN & LEGISLATION

As it ran in Shroom Scan

Psychedelic First for Binge Eating

Psychedelic First for Binge Eating

Swinburne University is launching the world’s first clinical trial using IV-administered psilocin to treat binge eating disorder. Unlike oral capsules, this method allows for precise control over the psychedelic experience and faster reversal if needed. Paired with talk therapy, the trial aims to offer relief for a deeply under-researched condition.

Swinburne University is launching the world’s first clinical trial using IV-administered psilocin to treat binge eating disorder. Unlike oral capsules, this method allows for precise control over the psychedelic experience and faster reversal if needed. Paired with talk therapy, the trial aims to offer relief for a deeply under-researched condition.

Healing Mushrooms, Addiction Breakthroughs, and Plastic-Free Packaging

Read the original study ↗

Get Shroom Scan

Next study

First Psilocybin Therapy Trial for Prolonged Grief After Cancer Loss ›

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.

See what's inside →